7 min read
Monthly FDA Guidance and Regulatory News Review - April 2026
This April 2026 regulatory update highlights new policies on biomarker validation, expanded access to investigational...
1 min read
Join Veristat and other Massachusetts life sciences companies at the MassBio Annual Meeting, as they discuss the most critical challenges in bringing new products to market.
Annual Meeting Highlights Include:
Keynotes speeches:
Opening Keynote by Kate Marshall, high school honors student, athlete and CF advocate
Closing Keynote by Dr. Tony Coles, Chairman & CEO, Yumanity Therapeutics
Remarks from special guests:
- Charlie Baker, Governor, Commonwealth of Massachusetts
- Congressman Richard Neal, Dean of the Mass. Delegation
- Rachel Kaprielian, HHS Regional Director
Discussion topics to include:
- The 2016 National Landscape
- Advanced Manufacturing
- Innovative Pricing Models: The Future is Now
- The Future of Finance & Capital Markets
- An Evolving Paradigm of Drug Discovery - Externalization, Virtualization, De-virtualization, Contract Research & Strategic Partnerships
- Digital Healthcare
- Technology in Clinical Trials
- The Microbiome
- Immunotherapy in Combination
- Biosimilars
Schedule a Meeting with Veristat
Take advantage of the time at the event and schedule a time to meet with Veristat. We are a full-service CRO that can help guide you through the entire clinical development and regulatory process. Whether you need help writing your protocol, preparing for your regulatory submissions or need a partner to help bring your product from IND to NDA, look to Veristat for a truly collaborative partnership.
